Acusnare
Payments companies reported to CMS as associated with Acusnare. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Acusnare, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Acusnare
These are the largest totals companies reported as associated with Acusnare. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Antonio Mendoza Ladd | Sacramento, CA | Gastroenterology (Internal Medicine) | $2,425.10 |
| Thomas Imperiale | Indianapolis, IN | Gastroenterology (Internal Medicine) | $2,260.00 |
| Laura Zigler | Mount Carmel, IL | Surgery | $17.43 |
| Mukul Arya | Brooklyn, NY | Gastroenterology (Internal Medicine) | $7.28 |
| Stephen Landreneau | New Orleans, LA | Gastroenterology (Internal Medicine) | $2.74 |
Prescribed Acusnare?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.